COVID-19 Effect on Surgery for Gastrointestinal Malignancies: Have Operative Volumes Recovered?
- PMID: 37749458
- DOI: 10.1007/s11605-023-05838-y
COVID-19 Effect on Surgery for Gastrointestinal Malignancies: Have Operative Volumes Recovered?
Abstract
Background: COVID-19 disrupted elective operations, cancer screening, and routine medical care while simultaneously overwhelming hospital staff and supplies. Operations for gastrointestinal (GI) malignancies rely on endoscopic screening, staging, and neoadjuvant therapy (NAT), each of which was disrupted by the pandemic. The aim was to evaluate the effect of the COVID-19 pandemic on the US national rates of gastrointestinal oncologic operations.
Methods: The Vizient Clinical Data Base® was queried for oncologic operations for esophageal, gastric, and colorectal malignancies with and without NAT from March 2019 to March 2022. Control chart analysis examined operative volume over time while Wilcoxon rank sum tests were used to compare mean monthly volume before and during the pandemic.
Results: A total of 95,912 patients were identified over 36 months; 5.8% esophageal, 6.3% gastric, 77.5% colonic, and 10.4% rectal operations. Esophageal operative volume decreased for 9 months during the pandemic and was significantly lower during than before the pandemic (p=0.002). Gastric operations decreased for 10 months early in the pandemic, but rebounded so that after 2 years volumes were unchanged (p=0.49). Colonic operations experienced a sharp decrease for 4 months at the beginning of the pandemic, but volumes quickly increased and overall were unchanged (p=0.29). Rectal operations decreased for 13 months and were significantly lower during than before the pandemic (p=0.018). Oncologic operations for patients receiving NAT varied.
Conclusion: COVID-19 significantly disrupted the volume of gastrointestinal oncologic operations in the USA. Esophageal and rectal oncologic operations experienced prolonged and significant reductions while gastric and colonic oncologic operations transiently decreased but rebounded during the pandemic.
Keywords: COVID-19 pandemic; Colorectal cancer; Esophageal cancer; Gastric cancer; Surgical oncology.
© 2023. The Society for Surgery of the Alimentary Tract.
Similar articles
-
Operative trends for pancreatic and hepatic malignancies during the COVID-19 pandemic.Surgery. 2024 Aug;176(2):364-370. doi: 10.1016/j.surg.2024.02.023. Epub 2024 Apr 6. Surgery. 2024. PMID: 38582733
-
The impact of the novel coronavirus pandemic on gastrointestinal operative volume in the United States.Surg Endosc. 2022 Mar;36(3):1943-1949. doi: 10.1007/s00464-021-08477-z. Epub 2021 Apr 19. Surg Endosc. 2022. PMID: 33871720 Free PMC article.
-
Effects of the COVID-19 pandemic on endocrine operations in the United States.Am J Surg. 2024 Feb;228:22-29. doi: 10.1016/j.amjsurg.2023.08.004. Epub 2023 Aug 19. Am J Surg. 2024. PMID: 37659868
-
Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.J Gastrointest Surg. 2020 Oct;24(10):2357-2373. doi: 10.1007/s11605-020-04712-5. Epub 2020 Jun 30. J Gastrointest Surg. 2020. PMID: 32607860 Free PMC article.
-
Could diagnostic and therapeutic delay affect the prognosis of gastrointestinal primary malignancies in the COVID-19 pandemic era?Minerva Surg. 2021 Oct;76(5):467-476. doi: 10.23736/S2724-5691.21.08736-8. Epub 2021 Apr 23. Minerva Surg. 2021. PMID: 33890444 Review.
References
-
- Miller FA, Young SB, Dobrow M, Shojania KG. Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ Quality & Safety. 2021;30(4):331-5. - DOI
-
- Murphy PD. Exective Order No. 109. 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical